Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys

American Journal of Pathology

Volumn 152, Issue 5, 1998, Pages 1225-1235

  Attar, Rehab ^a   Quinn, Feargal ^a   Winyard, Paul J D ^a   Mouriquand, Pierre D E ^a   Foxall, Peta ^a   Hanson, Mark A ^b   Woolf, Adrian S ^a,c  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHRONIC KIDNEY FAILURE; FETUS; GLOMERULUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY MALFORMATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; URINARY DYSFUNCTION; URINARY TRACT MALFORMATION; URINE FLOW RATE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL SURVIVAL; DNA-BINDING PROTEINS; FEMALE; FETAL DISEASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYDRONEPHROSIS; IMMUNOENZYME TECHNIQUES; KIDNEY; KIDNEY DISEASES, CYSTIC; ORGAN SIZE; PAX2 TRANSCRIPTION FACTOR; PREGNANCY; PROLIFERATING CELL NUCLEAR ANTIGEN; SHEEP; TRANSCRIPTION FACTORS; URETERAL OBSTRUCTION;

EID: 0031921439     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. McEnery PT, Stablein DM, Arbus G, Tejani A: Renal transplantation in children. N Engl J Med 1992, 326:1727-1732
2. Potter EL: Normal and Abnormal Development of the Kidney. Chicago, Year Book Medical Publishers, 1972
3. Coplen DE: Prenatal intervention for hydronephrosis. J Urol 1997, 157:2270-2277
4. Peters CA: Obstruction of the fetal urinary tract. J Am Soc Nephrol 1997, 8:653-663
5. Wintour EM, Alcorn D, Butkus A, Congiu, Earnest L, Pompolo S, Potocnik SJ: Ontogeny of hormonal and excretory function of the meso-and metanephros in the ovine fetus. Kidney Int 1996, 50:1624-1633
6. Beck AD: The effect of intrauterine urinary obstruction upon the development of the fetal kidney. J Urol 1971, 105:784-789
7. Tanagho EA: Surgically induced partial urinary obstruction in the fetal lamb. III. Ureteral obstruction. Invest Urol 1972, 10:35-52
8. Peters CA, Carr MC, Lais A, Retik AB, Mandell J: The response of the fetal kidney to obstruction. J Urol 1992, 148:503-509
9. Carr MC, Schlussel RN, Peters CA, Uchida T, Mandell J, Freeman MR: Expression of cell growth related genes in the fetal kidney: relevance to in utero obstruction. J Urol 1995, 154:242-246
10. Woolf AS: Multiple causes of human kidney malformations. Arch Dis Child 1997, 77:471-473
11. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax2, a new murme paired-box-containing gene, and its expression in the developing excretory system. Development 1990, 109:787-795
12. Winyard PJD, Risdon RA, Sams VR, Dressler GR, Woolf AS: The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 1996, 98:451-459
13. Rothenpieler UW, Dressler GR: Pax-2 is required for mesenchymeto-epithelium conversion during kidney development. Development 1993, 119:711-720
14. Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development Development 1995, 121: 4057-4065
15. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993, 362:65-67
16. Sanyanusin P, Schimmentl LA, McNoe LA, Ward TA, Pierpoint MEM, Sullivan MJ, Dobyns WB, Eccles MR: Mutations of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nature Genet 1995, 9:358-364
17. Koseki C, Herzlinger D, Al-Awqati Q: Apoptosis in metanephric development. J Cell Biol 1992, 119:1322-1333
18. Coles HSR, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 1993, 118:777-784
19. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon AR, Woolf AS: Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 1996, 49:135-146
20. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1994, 75:229-240
21. Sorenson CM, Rogers SA, Korsmeyer SJ, Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol 1995, 268:73-81
22. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. 1987. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987, 326:515-517
23. Gavrelli Y, Sheman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J Cell Biol 1992, 119:493-501
24. Mandell J, Peters CA, Estroff JA, Allred EN, Benacerraf BR: Human fetal compensatory renal growth. J Urol 1993, 150:790-792
25. Glazebrook KN, McGrath FP, Steele BT: Prenatal compensatory renal growth: documentation with US. Radiology 1994, 189:733-735
26. Peters CA, Gaertner RC, Carr MC, Mandell J: Fetal compensatory renal growth due to unilateral urethral obstruction. J Urol 1993, 150: 597-600
27. Dressler GR, Douglas EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992, 89:1179-1183
28. Phelps DA, Dressler GR: Identification of novel Pax-2 binding sites by chromatin precipitation. J Biol Chem 1996, 271:7978-7985
29. Winyard PJD, Bao Q, Hughes RC, Woolf AS: Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. J Am Soc Nephrol 1997, 8:1647-1657
30. Loughna S, Hardman P, Landels E, Jussila L, Alitalo K, Woolf AS: A molecular and genetic analysis of renal glomerular capillary development. Angiogenesis 1997, 1:84-101
31. Bernstein J: Glomerulocystic kidney disease: nosological considerations. Pediatr Nephrol 1993, 7:464-470
32. Matsell DG, Bennett T, Armstrong RA, Goodyer P, Goodyer C, Han VKM: Insulin-like growth factor and IGF binding protein gene expression in multicystic renal dysplasia. J Am Soc Nephrol 1997, 8:85-94
33. Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE: Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 1992, 3:279-289
34. Gnarra JR, Dressler GR: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 1995, 55:4092-4098
35. Maulbecker CC, Gruss P: The oncogenic potential of Pax genes. EMBO J 1993, 12:2361-2367
36. Stuart ET, Haffner R, Oren M, Gruss P: Loss of p53 function through PAX-mediated transcriptional repression. EMBO J 1995, 14:5638-5645
37. Granata C, Wang Y, Puri P, Tanaka K, O'Briain DS: Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis. Br J Urol 1997, 80:140-144
38. Mesrobian H-GJ, Rushton HG, Bulas D: Unilateral renal agenesis may result from in utero regression of multicystic dysplasia. J Urol 1993, 150:793-794
39. Yamada T, Horiuchi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996, 93:156-160
40. Yerkes E, Nishimura H, Hohenfellner K, Hunley TE, Yoshida H, Kon V, Philips JA III, Brock JW III, Ichikawa I: Association between the angiotensin type 2 receptor (AT2) genotype and congenital urinary tract anomalies in two independent cohorts. J Am Soc Nephrol 1997, 8:397A
41. Feather SA, Winyard PJD, Dodd S, Woolf AS: Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred. Nephrol Dial Transplant 1997, 12:1354-1361
42. Feather S, Woolf AS, Malcolm S, Donnai D, Winter R: The oral-facial-digital syndrome type 1, a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-22.3. Hum Mol Genet 1997, 7:1163-1167
43. Gage JC, Sulik KK: Pathogenesis of ethanol-induced hydronephrosis and hydroureter as demonstrated following in vivo exposure of mouse embryos. Teratology 1991, 44:299-312
44. Chevalier RL, Thornhill BA, Gomez RA: EDRF modulates renal hemodynamics during unilateral obstruction in the rat. Kidney Int 1992, 42:400-406
45. Peters C, Belman AB: Urinary tract obstruction in children. J Urol 1995, 154:1874-1884
46. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 1996, 50:200-207
47. Kaneto H, Morrisey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 1993, 44:313-321
48. Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet-Benichou C: Effects of prenatal and postnatal exposure to gentamycin on renal differentiation in the rat. Toxicology 1987, 43:301-313
49. Chevalier RL: Growth factors and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol 1996, 7:1098-1105
50. Berman DJ, Maizels M: The role of urinary obstruction in the genesis of renal dysplasia: a model in the chick embryo. J Urol 1982, 128: 1091-1096
51. Tanner GA, McQuillan PF, Maxwell MR, Keck JK, McAteer JA: In vitro test of the stretch-proliferation hypothesis of renal cyst enlargement. J Am Soc Nephrol 1995, 6:1230-1241
52. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 1995, 5:1462-1468
53. Woo DDL, Miao S, Pelayo J, Woolf AS: Taxol inhibits progression of congenital polycystic kidney disease. Nature 1994, 368:750-753
54. Grantham JJ: Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 1992, 3:1841-1857
55. Foxall PJD, Price RG, Jones NK, Nield GH, Thompson FD, Nicholson JK: High resolution proton magnetic resonance spectroscopy of cyst fluid from patients with polycystic kidney disease. Biochim Biophys Acta 1992, 1138:305-314
56. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 1996, 87:979-987
57. Woolf AS, Cale CM: Roles of growth factors in renal development. Curr Opin Nephrol Hypertens 1997, 6:10-14
58. Rogers SA, Ryan G, Purchio AF, Hammerman MR: Metanephric transforming growth factor β1 regulates nephrogenesis in vitro. Am J Physiol 1993, 264:F996-F1002
59. Woo DDL: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995, 333:18-25
60. Steinhardt GF, Liapis H, Philips B, Vogler G, Nag M, Yoon K-W: Insulin-like growth factor improves renal architecture of fetal kidneys with complete ureteral obstruction. J Urol 1995, 154:690-693